검색결과 : 6건
| No. | Article |
|---|---|
| 1 |
Tumour lineage shapes BRCA-mediated phenotypes (vol 571, pg 576, 2019) Jonsson P, Bandlamudi C, Cheng ML, Srinivasan P, Chavan SS, Friedman ND, Rosen EY, Richards AL, Bouvier N, Selcuklu SD, Bielski CM, Abida W, Mandelker D, Birsoy O, Zhang LY, Zehir A, Donoghue MTA, Baselga J, Offit K, Scher HI, O'Reilly EM, Stadler ZK, Schultz N, Socci ND, Viale A, Ladanyi M, Robson ME, Hyman DM, Berger MF, Solit DB, Taylor BS Nature, 577(7789), E1, 2020 |
| 2 |
Single-cell mutation analysis of clonal evolution in myeloid malignancies Miles LA, Bowman RL, Merlinsky TR, Csete IS, Ooi AT, Durruthy-Durruthy R, Bowman M, Famulare C, Patel MA, Mendez P, Ainali C, Demaree B, Delley CL, Abate AR, Manivannan M, Sahu S, Goldberg AD, Bolton KL, Zehir A, Rampal R, Carroll MP, Meyer SE, Viny AD, Levine RL Nature, 587(7834), 477, 2020 |
| 3 |
Single-cell mutation analysis of clonal evolution in myeloid malignancies Miles LA, Bowman RL, Merlinsky TR, Csete IS, Ooi AT, Durruthy-Durruthy R, Bowman M, Famulare C, Patel MA, Mendez P, Ainali C, Demaree B, Delley CL, Abate AR, Manivannan M, Sahu S, Goldberg AD, Bolton KL, Zehir A, Rampal R, Carroll MP, Meyer SE, Viny AD, Levine RL Nature, 587(7834), 477, 2020 |
| 4 |
Tumour lineage shapes BRCA-mediated phenotypes Jonsson P, Bandlamudi C, Cheng ML, Srinivasan P, Chavan SS, Friedman ND, Rosen EY, Richards AL, Bouvier N, Selcuklu SD, Bielski CM, Abida W, Mandelker D, Birsoy O, Zhang LY, Zehir A, Donoghue MTA, Baselga J, Offit K, Scher HI, O'Reilly EM, Stadler ZK, Schultz N, Socci ND, Viale A, Ladanyi M, Robson ME, Hyman DM, Berger MF, Solit DB, Taylor BS Nature, 571(7766), 576, 2019 |
| 5 |
CANCER Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response Mandal R, Samstein RM, Lee KW, Havel JJ, Wang H, Krishna C, Sabio EY, Makarov V, Kuo FS, Blecua P, Ramaswamy AT, Durham JN, Bartlett B, Ma XX, Srivastava R, Middha S, Zehir A, Hechtman JF, Morris LGT, Weinhold N, Riaz N, Le DT, Diaz LA, Chan TA Science, 364(6439), 485, 2019 |
| 6 |
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy Chowell D, Morris LGT, Grigg CM, Weber JK, Samstein RM, Makarov V, Kuo FS, Kendall SM, Requena D, Riaz N, Greenbaum B, Carroll J, Garon E, Hyman DM, Zehir A, Solit D, Berger M, Zhou RH, Rizvi NA, Chan TA Science, 359(6375), 582, 2018 |